AI Research

Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies | AI Learning Platform

MultimodalReasoning

Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies

Jungkyu Park, Dhruva Biswas, Joseph Cappadona et al.1 min readarXivOct 2, 2026

Key Takeaway for Students

Scarcity of labeled data limits development of deep learning biomarkers in oncology. We develop a two-stage AI model predicting pathological complete response (pCR) to neoadjuvant therapy in breast cancer. The first stage learns the transcriptome from histopathology using 8,742 patients across 32 cancer types, corroborated by pathologist review and spatial agreement with measur

95% CIoutperforms histopathological biomarkers, remaining stable across intr

Reading in Plain English mode — toggle below to switch

Read original on arXiv

Career Insight

medium demand

Why it matters

This paper demonstrates a novel approach to developing deep learning biomarkers in oncology by integrating histopathology and transcriptomics. It addresses the common challenge of limited labeled data in medical AI by using a two-stage model, which is a valuable strategy for ML engineers working in data-scarce domains. The successful application in predicting neoadjuvant therapy response highlights the potential of multimodal AI in personalized medicine.

Skills to learn

Develop and implement multi-stage deep learning architecturesIntegrate and fuse multimodal data (e.g., imaging and omics data)Techniques for transfer learning and pre-training in medical imagingStrategies for handling limited labeled data in deep learningEvaluation metrics and methodologies for clinical AI models (e.g., AUROC, confidence intervals)

Interview questions

Describe the challenges of developing deep learning models for medical applications with limited labeled data, and how this paper attempts to address them.
Explain the 'two-stage AI model' proposed in the paper. What are the advantages of this approach compared to a single-stage end-to-end model for predicting pCR?
Design a system for deploying this multi-modal AI model for breast cancer prognosis in a hospital setting, considering data privacy, computational resources, and integration with existing clinical workflows.

Relevant for ~18 months · generated by the enrichment pipeline